1. Home
  2. Analysis
  3. Camptosar
  4. Gingivitis-aggravated

Camptosar and Gingivitis aggravated - a phase IV clinical study of FDA data

Summary:

Gingivitis aggravated is reported as a side effect among people who take Camptosar (irinotecan hydrochloride), especially for people who are male, 60+ old, also take Leucovorin Calcium, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Gingivitis aggravated when taking Camptosar. It is created by eHealthMe based on reports of 7,116 people who have side effects when taking Camptosar from the FDA, and is updated regularly.

What is Camptosar?

Camptosar has active ingredients of irinotecan hydrochloride. eHealthMe is studying from 7,145 Camptosar users. Check the latest studies of Camptosar.

What is Gingivitis aggravated?

Gingivitis aggravated (infection of gums) is found to be associated with 760 drugs and 212 conditions by eHealthMe. Check the latest studies of Gingivitis aggravated.

On Apr, 25, 2026

7,116 people reported to have side effects when taking Camptosar.
Among them, 11 people (0.15%) have Gingivitis aggravated.

Could Camptosar cause Gingivitis aggravated?

Among these 11 people:

What is the gender of people who have Gingivitis aggravated when taking Camptosar? *

  • female: 18.18 %
  • male: 81.82 %

What is the age of people who have Gingivitis aggravated when taking Camptosar? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 9.09 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 18.18 %
  • 60+: 72.73 %

What are other drugs people take besides Camptosar? *

  1. Fluorouracil: 10 people, 90.91%
  2. Leucovorin Calcium: 10 people, 90.91%
  3. Ambien: 9 people, 81.82%
  4. Neulasta: 9 people, 81.82%
  5. Avastin: 9 people, 81.82%
  6. Aranesp: 9 people, 81.82%
  7. Protonix: 9 people, 81.82%
  8. Zosyn: 8 people, 72.73%
  9. Lasix: 8 people, 72.73%
  10. Zometa: 8 people, 72.73%

What are other side effects people have besides Gingivitis aggravated? *

  1. Diarrhea: 9 people, 81.82%
  2. Death: 9 people, 81.82%
  3. Sinusitis (inflammation of sinus): 9 people, 81.82%
  4. Depression: 8 people, 72.73%
  5. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall): 8 people, 72.73%
  6. Dyspnea (difficult or laboured breathing): 8 people, 72.73%
  7. Enlarged Heart: 8 people, 72.73%
  8. Enterococcal Infection: 8 people, 72.73%
  9. Erection Problems: 8 people, 72.73%
  10. Excoriation (to tear or wear off the skin of): 8 people, 72.73%

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 8 people, 72.73%
  2. Brain Neoplasm Malignant (brain cancer tumour): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Camptosar and have Gingivitis aggravated?

- Check whether Gingivitis aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Camptosar:

Gingivitis aggravated treatments and more:

How severe was Gingivitis aggravated and when was it recovered:

Expand to all the drugs that have ingredients of irinotecan hydrochloride:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Camptosar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gingivitis aggravated:

Browse all the conditions that are associated with Gingivitis aggravated:

How the study uses the data?

The study uses data from the FDA. It is based on irinotecan hydrochloride (the active ingredients of Camptosar) and Camptosar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.